Literature DB >> 33039280

Percutaneous Left Ventricular Assist Device Leads to Heart Rhythm Stabilisation in Cardiogenic Shock: Results from the Dresden Impella Registry.

Johannes Mierke1, Tobias Loehn2, Georg Ende3, Sabrina Jahn3, Silvio Quick4, Uwe Speiser3, Stefanie Jellinghaus3, Christian Pfluecke3, Axel Linke3, Karim Ibrahim4.   

Abstract

BACKGROUND: Severe heart rhythm disturbances (SHRDs) occur regularly in cardiogenic shock (CS). Percutaneous left ventricular assist devices (pLVADs) can actively unload the left ventricle (LV), decreasing left ventricular end-diastolic pressure and wall tension, which are suspected parameters for the induction and maintenance of arrhythmias. The aim of this study was to describe effects of LV unloading on SHRD.
METHOD: In the Dresden Impella Registry, 97 patients received an Impella CP in refractory CS. Of them, 19 had SHRDs, which were not stopped by common therapeutic strategies such as electrical defibrillation or antiarrhythmic drugs. They were only stopped after implantation of a micro-axial heart pump. This phenomenon was referred to as heart rhythm stabilisation (HRS). Clinical outcome and laboratory parameters were assessed and risk factors for the occurrence of HRS were identified.
RESULTS: All 19 patients with refractory SHRD terminated immediately into a stable heart rhythm after insertion of the micro-axial heart pump. In 37% no additional defibrillation was needed. Of the patients with HRS, CS was mostly caused by myocardial infarction (68%). Resuscitation before pLVAD was performed in 89% for more than 30 minutes. Patients with HRS were resuscitated more frequently and for a longer duration than patients without HRS. After HRS, the serum lactate and norepinephrine dosage decreased in the first 12 hours, whereas left ventricular ejection fraction increased by 95%.
CONCLUSIONS: Left ventricular unloading in patients with CS seems to be an option for treating patients with sustained life-threatening tachycardia, who are refractory to common treatment.
Copyright © 2020 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiogenic shock; Electrical storm; Impella; Percutaneous left ventricular assist devices; Ventricular arrhythmia

Year:  2020        PMID: 33039280     DOI: 10.1016/j.hlc.2020.08.005

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  2 in total

1.  Predictive value of the APACHE II score in cardiogenic shock patients treated with a percutaneous left ventricular assist device.

Authors:  Johannes Mierke; Thomas Nowack; Tobias Loehn; Franziska Kluge; Frederike Poege; Uwe Speiser; Felix Woitek; Norman Mangner; Karim Ibrahim; Axel Linke; Christian Pfluecke
Journal:  Int J Cardiol Heart Vasc       Date:  2022-03-30

2.  Impact of Percutaneous Mitral Valve Repair Using the MitraClipTM System on Ventricular Arrhythmias and ICD Therapies.

Authors:  Nicolas A Geis; Anna Göbbel; Michael M Kreusser; Tobias Täger; Hugo A Katus; Norbert Frey; Philipp Schlegel; Philip W Raake
Journal:  Life (Basel)       Date:  2022-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.